Hydroxyamine hydrochloride → HCID 86738350, compound
Reaction equation
[C:1]([C:4]1[CH:5]=[CH:6][C:7]2[N:13]([CH3:14])[C:12](=[O:15])[C:11]([CH3:17])([CH3:16])[N:10]=[C:9]([C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=3[F:24])[C:8]=2[CH:25]=1)(=O)[CH3:2].Cl.[NH2:27][OH:28]>N1C=CC=CC=1>[F:24][C:19]1[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=1[C:9]1[C:8]2[CH:25]=[C:4]([C:1](=[N:27][OH:28])[CH3:2])[CH:5]=[CH:6][C:7]=2[N:13]([CH3:14])[C:12](=[O:15])[C:11]([CH3:17])([CH3:16])[N:10]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 13.66 g (40.37 mmol) of 7-acetyl-5-(o-fluorophenyl)-1,3-dihydro-1,3,3-trimethyl-2H-1,4-benzodiazepin-2-one and 13.6 g (0.196 mol) of hydroxylamine hydrochloride in 50 ml of pyridine is stirred at room temperature for 18 hours, then poured on to ice and extracted with methylene chloride/ethanol (9:1). The organic phase is washed successively with 3 N hydrochloric acid and water, dried and evaporated. The residue is chromatographed on 150 g of silica gel using methylene chloride as the elution agent and there is obtained, from ether, 5-(o-fluorophenyl)-1,3-dihydro-7-[1-(hydroxyimino)-ethyl]-1,3,3-trimethyl-2H-1,4-benzodiazepin-2-one of melting point 199°.
Workup
- additionpoured on to ice
- extractionextracted with methylene chloride/ethanol (9:1)
- washThe organic phase is washed successively with 3 N hydrochloric acid and water
- customdried
- customevaporated
- customThe residue is chromatographed on 150 g of silica gel
Sources & evidence
- ORD record
- ord-10d9447a2bb04307a0c62eda090d91e8
- Source dataset
- uspto-grants-1982_04
- Patent number
- US04327026
Reaction notes
Loading…